Legal Representation
Attorney
                                            Richard S. Vermut
                                        USPTO Deadlines
                                Next Deadline
                            
                            
                                    
                                        
                                        777 days remaining
                                    
                            
                        Section 8 (6-Year) Declaration Due (Based on registration date 2021-12-21)
                                    
                                    Due Date
                                
                                
                                    December 21, 2027
                                
                            
                                        
                                        Grace Period Ends
                                    
                                    
                                        June 21, 2028
                                    
                                
                            
                            Additional deadlines exist. Contact your attorney for complete deadline information.
                        
                Application History
31 events| Date | Code | Type | Description | Documents | 
|---|---|---|---|---|
| Dec 21, 2021 | R.SR | A | REGISTERED-SUPPLEMENTAL REGISTER | Loading... | 
| Nov 17, 2021 | AAUA | E | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | Loading... | 
| Nov 16, 2021 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... | 
| Nov 16, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... | 
| Nov 16, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... | 
| Nov 16, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... | 
| Nov 16, 2021 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... | 
| Nov 16, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... | 
| Nov 16, 2021 | IUAA | P | USE AMENDMENT ACCEPTED | Loading... | 
| Nov 16, 2021 | CNTA | O | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | Loading... | 
| Nov 16, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... | 
| Nov 15, 2021 | ALIE | A | ASSIGNED TO LIE | Loading... | 
| Nov 9, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... | 
| Nov 9, 2021 | IUAF | S | USE AMENDMENT FILED | Loading... | 
| Nov 9, 2021 | AUPC | I | AMENDMENT TO USE PROCESSING COMPLETE | Loading... | 
| Nov 8, 2021 | EAAU | I | TEAS AMENDMENT OF USE RECEIVED | Loading... | 
| Jun 22, 2021 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... | 
| Jun 22, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... | 
| Jun 22, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... | 
| May 17, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... | 
| May 17, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... | 
| May 17, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... | 
| May 7, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... | 
| May 6, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... | 
| May 6, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... | 
| Nov 9, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... | 
| Nov 9, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... | 
| Nov 9, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... | 
| Nov 2, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... | 
| Aug 17, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... | 
| Jul 23, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... | 
Detailed Classifications
                                                Class 035
                                            
                                        Trade association services, namely, promoting the interests of endocrinologists through education, advocacy and promotion of the field of clinical endocrinology, diabetes, and metabolism
                                        
                                                    
                                                    First Use Anywhere: 
20201100                                                    
                                                
                                                
                                                    
                                                    First Use in Commerce: 
20201100                                                    
                                                
                                        
                                                Class 041
                                            
                                        Providing continuing medical education courses in the fields of clinical endocrinology, diabetes, and metabolism; Providing on-line continuing medical education courses in the fields of clinical endocrinology, diabetes, and metabolism
                                        
                                                    
                                                    First Use Anywhere: 
20201100                                                    
                                                
                                                
                                                    
                                                    First Use in Commerce: 
20201100                                                    
                                                
                                        
                                                Class 042
                                            
                                        Providing on-line medical and scientific research information in the fields of clinical endocrinology, diabetes, and metabolism
                                        
                                                    
                                                    First Use Anywhere: 
20201100                                                    
                                                
                                                
                                                    
                                                    First Use in Commerce: 
20201100                                                    
                                                
                                        
                                                Class 044
                                            
                                        Providing on-line medical information in the fields of clinical endocrinology, diabetes, and metabolism
                                        
                                                    
                                                    First Use Anywhere: 
20201100                                                    
                                                
                                                
                                                    
                                                    First Use in Commerce: 
20201100                                                    
                                                
                                        Classification
                                            
                                            International Classes
                                        
                                        
                                                    035
                                                    041
                                                    042
                                                    044
                                            
                                        Disclaimers
                                    
                                    The following terms have been disclaimed and are not claimed as part of the trademark:
                                
                                    
                                                Specific Disclaimer
                                        
                                        
                                            "ASSOCIATION"